AstraZeneca (NASDAQ:AZN) Stock Rating Upgraded by UBS Group
UBS Group upgraded shares of AstraZeneca (NASDAQ:AZN – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. A number of other equities research analysts have also recently commented on AZN. Deutsche Bank Aktiengesellschaft raised shares of AstraZeneca from a “sell” rating […]
UBS Group upgraded shares of AstraZeneca (NASDAQ:AZN – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. A number of other equities research analysts have also recently commented on AZN. Deutsche Bank Aktiengesellschaft raised shares of AstraZeneca from a “sell” rating […]
